BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
The company intends to use the net proceeds from the offering to purchase gold bullion and for general corporate purposes.
Public Offering Announcement
BioSig Technologies, Inc. plans to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used to purchase gold bullion and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering remains subject to market conditions with no assurance regarding timing, size, or terms.
- Investors are advised to read the preliminary prospectus and other documents filed with the SEC for more information about the offering.
BioSig Technologies Inc.'s proposed public offering showcases its strategic move to raise funds for specific purposes, showing a clear business focus and investment direction.